- Science
- Clinical Trials
- Guide to Clinical Trials Your participation makes a difference
- Clinical Trials in Children Designed to improve kids' health
- Data and Results Sharing our Results
- Integrity and Transparency Building Trust
- Diversity Equity and Representation
- Plain Language Study Results Trial Result Summaries
- Expanded Access & Compassionate Use Possible Treatment Options
- Find a Trial
- Areas of Focus
- Rare Disease Smaller populations but big impact
- Internal Medicine Extending lifespans worldwide
- Inflammation & Immunology Treatment at the molecular level
- Vaccines Preventing the spread of infections
- Oncology The science of optimism
- Anti Infectives Combatting an evolving risk
- Areas of Innovation
- Gene Therapy Breakthroughs become treatments
- Medicinal Sciences The next generation of science
- Precision Medicine Developing tailored medicines
- Maternal Immunization Protecting newborns at the start
- mRNA Technology Unleashing the next wave of scientific innovations
- Diseases & Conditions
- Coronavirus Resources
- Product Pipeline
- Research Sites
- Clinical Trials
- Products
- How Drugs are Made
- Branded vs. Generic Learn the difference
- Biologics & Biosimilars Cures found in nature
- Commitment to Quality Maintaining the highest standards
- Global Supply Strategic manufacturing locations
- Manufacturing Sites Where medicine is made in the U.S.
- Medicine Safety
- Health Literacy Learning to be well
- Treatment Choices Learning about treatment decisions
- Partnering With Patients Helping others by reporting side effects
- Tips for Patients Preventing medication errors
- Reporting Adverse Events
- Counterfeiting Preventing medication errors
- Safety Data Sheets
- Product List
- Product Contacts
- PfizerPro for Professionals
- Patient Assistance Programs
- Distributors
- How Drugs are Made
- Stories
- Newsroom
- About
- People
- Executives Our senior-most leadership
- Board Members The people steering our company
- Scientists Our experts making discoveries
- Patient Stories Our patients
- Colleague Stories Our colleagues
- Responsibility
- Ethics & Compliance Each of us is responsible
- Diversity, Equity, and Inclusion Everyone has something to offer
- EHS Governance
- Environmental Sustainability Our responsiblity to the environment
- Global Impact Meeting urgent needs worldwide
- Health & Safety
- Human Rights Furthering dignity and worth
- Intellectual Property The benefits of fair competition
- Patient Advocacy & Engagement Putting Patients First
- Misinformation
- Programs & Policies
- Grants Support for independent research
- Political Partnership Supporting like-minded organizations
- Working with Healthcare Professionals Collaboration to improve lives
- Prescription Value & Pricing How to lower patient costs
- Privacy Principles Commitment to personal data privacy
- Ready for Cures Improving Access to Medicines
- Transparency in Grants Committed to Disclosure
- Investors
- Investors Overview Information for stockholders
- Why Invest Why to join us in our mission
- Events & Presentations Calendar of upcoming events
- Financial Reports Quarterly reports and more
- Investor News Announcements about our performance
- Stock Information Charts and data
- Shareholder Services Information on stock transactions
- Corporate Governance
- Corporate Governance Overview Gaining insight into our performance
- Board Committees & Charters Defining the corporate structure
- The Pfizer Board Policies Ensuring ethical leadership
- Corporate Governance FAQs Learn more about our approach
- Contact Our Directors Email any of our Directors
- Purpose
- History
- Careers
- Partners
- People
The Antigen Podcast
Share
The Antigen podcast goes behind the science of vaccines. We examine basic science principles, review vaccine history, explore the many facets of their global impact (including COVID-19), and the public sentiment about vaccines around the world.
Season 1 is an eight-part audio-documentary style podcast about the scientific, cultural, and political elements of vaccination. Hear from leading experts about the past, present, and future of this important innovation, as well as people whose families have been impacted by vaccine-preventable diseases.
Season 2 focuses on COVID-19, connecting with experts to give accurate information and updates on the global response to the pandemic. Over the course of the four-part mini-series, we look back at past global health emergencies, discuss efforts across the industry to research potential coronavirus vaccines and treatments, and look ahead to life after a crisis.
Season 3 returns with a three-part mini-series spotlighting maternal immunization. When it comes to vaccine development, there is a shifting paradigm – help protect pregnant women and their infants through research rather than from research. Join expert guests as they discuss the history, the challenges, the innovations, and the potentially exciting developments to come.
Hosts
Season 1 of The Antigen is hosted by Yasmeen Agosti, MD FAAP. Yasmeen is a pediatrician and a Global Medical Lead, Viral Vaccines at Pfizer. She is a Ph.D. candidate in Clinical Microbiology and Infectious Diseases at the University of Witwatersrand. Yasmeen trained as a general pediatrician in Philadelphia and, later, conducted clinical research on respiratory syncytial virus in South Africa as part of her doctoral studies. She joined Pfizer in 2017.
Learn more about her background and current work at Pfizer
Season 2 is hosted by Lindsey Dietschi. As the Vice President, Global Health Partnerships Lead in Pfizer's Emerging Markets, Lindsey led a team that established partnerships to bring Pfizer medicines and vaccines to people in Africa, Asia, and Latin America. She has worked at Pfizer for nearly 19 years and in vaccines for more than 10 years, including serving as the representative of the developed world vaccine manufacturers on the Programme and Policy Committee of Gavi, the Vaccine Alliance. Lindsey has a Bachelor of Arts from Michigan State University and Master of Business Administration from the Stern School of Business at New York University, where she is also currently an Adjunct Professor in the Management Communications department.
Season 3 is hosted by Kari Yacisin, MD, MSc. She is an infectious disease physician and a Senior Medical Director in Vaccines at Pfizer, and has over 14 years of experience in the medical field and public health. She trained in Internal Medicine and Infectious Diseases, and then completed training with CDC’s Epidemic Intelligence Service. She worked in public health for several years before returning to clinical work and seeing patients. In 2019, she joined Pfizer Vaccines Clinical Research and Development as a Medical Monitor, and in 2021 moved to her current role as a U.S. Medical Affairs Pipeline Vaccines Lead.
*Guests have not been compensated for their participation on this podcast.